LWLiqun Wu

Liqun Wu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Liqun Wu has a total of 29 co-authors. Here are the top co-authors by number of shared publications:

  • Hong Chen

    Department of Pediatrics, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China

    2 shared publications
  • Jie Wang

    Guizhou University of Traditional Chinese Medicine, Guiyang, China

    2 shared publications
  • Ye Zhang

    Yunnan Provincial Hospital of Traditional Chinese Medicine, Kunming, China

    2 shared publications
  • Yuhang Chen

    Department of Pediatrics, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China

    2 shared publications
  • Ziwei Zhang

    Department of Pediatrics, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China

    2 shared publications
  • Aimin Xu

    State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong, Hong Kong, China

    1 shared publication

Latest Publications

  • Open Access

    Development of an explainable machine learning asthma prediction model using serum brominated flame retardants in a national population

    by Xin Pan, Qiong Wang, Che Li, Jiawei Huang, Liqun Wu, Wenquan Niu

    We aimed to explore the association of serum brominated flame retardant (BFR) metabolites and mixture profiles with asthma risk among US adults. Data were sourced from the National Health and Nutrition Examination Survey (NHANES), 1999–2023. Four machine learning methods (light gradient boosting machine, eXtreme gradient boosting [XGBoost], random forest, and neural network) annexed with SHapley Additive exPlanations (SHAP) and one traditional logistic regression were used to develop and validate an explainable asthma prediction model. This study included 9,948 US adults. XGBoost outperformed other models with the highest area under the curve (AUC) at 0.814. Sixteen features—family history, BMI, PBDE47, PBDE28, PBDE154, age, race/ethnicity, smoking, second-hand smoking, sex, education, PIR, marriage, drinking, PBDE153, and PBB153—identified by at least two of applied methods were ultimately entered into machine learning models. According to the SHAP-quantified contribution to asthma risk, five key BFRs in predicting asthma were identified: PBDE47, PBDE28, PBDE154, PBDE153, and PBB153. Our findings indicated that XGBoost model proved most effective in predicting adulthood asthma based on serum BFRs. This machine learning-based model holds substantial promise for the early prevention, risk stratification, and clinical management of asthma.

  • Open Access

    Investigation of key ferroptosis-associated genes and potential therapeutic drugs for asthma based on machine learning and regression models

    by Yuhang Chen, Jie Wang, Ye Zhang, Ziwei Zhang, Hong Chen, Jiaojiao Hu, Ke Zhu, Liqun Wu, Fangwei Xu

    Bronchial asthma is a complex and heterogeneous disease, with ferroptosis, a form of non-apoptotic cell death, contributing to its pathogenesis by inducing airway epithelial damage, inflammatory infiltration, and airway remodeling. Investigating ferroptosis-related characteristic genes and potential therapeutic compounds may enhance asthma management. This study employed differential analysis and machine learning to identify ferroptosis-related characteristic genes in asthma using the GSE179156 dataset and FerrDb V2 database. Immune infiltration analysis explored the associations between these genes and immune cells, while potential small-molecule drugs were screened through the Connectivity Map (CMap) database and evaluated via molecular docking and molecular dynamics simulations. Two ferroptosis-related characteristic genes, AGPS and APELA, were identified, with AGPS upregulated and APELA downregulated in asthma, both significantly correlated with various immune cells. A diagnostic model based on these genes demonstrated high predictive accuracy. Additionally, KU-55933 was identified as a potential small-molecule inhibitor of AGPS, with stable binding confirmed through computational simulations. These findings emphasize the role of ferroptosis-related genes in asthma and propose promising therapeutic candidates, providing novel insights into its diagnosis and treatment.


  • Open Access

    Clinical management of children with tic disorder: insights from therapeutic visits in China—a real-world study

    by Jing Wang, Changyong Luo, Zhendong Wang, Tiegang Liu, Chen Bai, Yang Wang, Yuanshuo Tian, Qianqian Li, Zhaoxin Wang, Liqun Wu, et al.

    Objective: This retrospective study aims to investigate the treatment of tic disorder (TD) in Dongfang Hospital affiliated with Beijing University of Chinese Medicine, explore its underlying mechanism, and provide valuable insights for future research and clinical management of TD.Methods: The electronic medical records of children with TD, from 2015 to 2021, were extracted from the information system of Dongfang Hospital affiliated with Beijing University of Chinese Medicine. The clinical characteristics of TD, utilization patterns of Chinese herbal medicine and synthetic drugs in prescriptions, as well as their pharmacological effects, were statistically described and categorized. In addition, association rules and network pharmacology were employed to identify core prescriptions (CPs) and elucidate their microscopic molecular mechanisms in treating TD.Results: The age range of the children was from 6 to 11 years, with a higher proportion of male participants than female ones. The average duration of treatment was 6 weeks. Regimen Z for the treatment of TD can be summarized as follows: Chinese herbal medicine [Saposhnikoviae Radix (FangFeng), Puerariae Lobatae Radix (GeGen), Uncariae Ramulus cum Uncis (GouTeng), Acori Tatarinowii Rhizoma (ShiChangPu), Chuanxiong Rhizoma (ChuanXiong)] and vitamins [lysine, inosite, and vitamin B12 oral solution] form the basic treatment, combined with immunomodulators, antibiotics, electrolyte-balancing agents, and antiallergic agents. CPs primarily exerted their effects through the modulation of gene expression (transcription), the immune system, and signal transduction pathways, with interleukin-4 and interleukin-13 pathways being particularly crucial. Among the lysine synthetic drugs used, inosite and vitamin B12 oral solution were the most frequently prescribed.Conclusion: The regimen Z drug treatment holds significant importance in the field, as it exerts its therapeutic effects through a multitude of pathways and intricate interventions. Chinese herbal medicine primarily regulates immune system–related pathways, while synthetic drugs predominantly consist of vitamins.


  • Open Access

    Efficacy of Chinese herbal medicine on nasal itching in children with allergic rhinitis: a systematic review and meta-analysis

    by Yuhang Chen, Jie Wang, Liqun Wu, Ye Zhang, Hong Chen, Ziwei Zhang

    Background: Allergic rhinitis is prevalent among children and can cause nasal itching, fatigue, and even hinder growth and development. The main discomfort symptom of allergic rhinitis is nasal itching. Clinical reports suggest that Chinese herbal medicine (CHM) is effective in allergy rhinitis treatment. Therefore, we evaluate the clinical efficacy of Chinese herbal medicine in treating nasal itching caused by allergic rhinitis in children.Methods: Nine databases, including PubMed, Embase, The Cochrane Library, Web of Science, China National Knowledge Infrastructure, Wan Fang Data, CQVIP, Chinese Biological Medicine, and ClinicalTrials.gov, were systematically searched from their inception until March 2023. Randomized controlled trials (RCTs) comparing the efficacy of Chinese herbal medicine, either alone or in combination with Western medicine, to Western medicine treatment or placebo intervention for treating allergic rhinitis in children were eligible for inclusion. The effectiveness of Chinese herbal medicines for nasal itching was mainly evaluated. The Risk of Bias tool 2.0 assessed the risk of bias. Statistical analysis using RevMan 5.3 and Stata/SE 12. The quality of evidence was evaluated by GRADEpro 3.6. Risk ratios (RR) with corresponding 95% confidence intervals (CI) were utilized to evaluate and present dichotomous data, while mean difference (MD) and standardized mean difference (SMD) were employed for continuous data. A fixed-effects model was applied in cases where the data exhibited homogeneity (p > 0.1, I2 < 50%), whereas a random-effects model was utilized for heterogeneous data. Statistical significance was determined by a p-value Results: The review incorporated 23 studies. The meta-analysis indicated that herbal medicine was significantly related to the reduction of nasal itching (MD = −0.59, 95%CI: −0.94–0.24) and the increase of interleukin 10 level (SMD = 1.47, 95% CI: 0.90–2.05). Compared to Western medicine, the combining herbs and Western medicine showed better efficacy in relieving nasal itching, inhibiting immunoglobulin E, interleukin 4 and 33, enhancing interleukin 10, improving therapeutic efficiency, and reducing recurrent. Oral herbal medicine was more effective in treating nasal itching (MD = −0.45, 95% CI: −0.62–0.29). Combining oral and external herbal medicines was more efficient in treating nasal itching (MD = −0.44, 95% CI: −0.54–0.33), inhibiting immunoglobulin E, interleukin 4 (SMD = −0.87, 95% CI: −1.24–0.50) and 33 (SMD = −1.16, 95% CI: −1.54–0.77), and improving therapeutic efficiency. External herbal medicine did not show differences compared to Western medicines. Regarding safety, herbal medicine alone exhibited fewer adverse events than Western medicine; combining herbal and Western medicine showed no significant variation in adverse event incidence.Conclusion: Chinese herbal medicine (CHM) holds great potential in alleviating symptoms, modulating immune factors levels, and reducing relapse in pediatric rhinitis. Meanwhile, CHM is relatively safe. However, the efficacy and safety of CHM in treating pediatric rhinitis still need to be confirmed due to the inclusion of studies with low methodological quality, small sample sizes, and potential heterogeneity. More high-quality research is necessary to provide reliable evidence for the clinical application of CHM.Systematic Review Registration: INPLASY.com, identifier INPLASY202340076


  • Open Access

    Pathophysiological Insight into Fatty Acid-Binding Protein-4: Multifaced Roles in Reproduction, Pregnancy, and Offspring Health

    by Yue Shi, Chi-Chiu Wang, Liqun Wu, Yunqing Zhang, Aimin Xu, Yao Wang

    Fatty acid-binding protein-4 (FABP4), commonly known as adipocyte-fatty acid-binding protein (A-FABP), is a pleiotropic adipokine that broadly affects immunity and metabolism. It has been increasingly recognized that FABP4 dysfunction is associated with various metabolic syndromes, including obesity, diabetes, cardiovascular diseases, and metabolic inflammation. However, its explicit roles within the context of women’s reproduction and pregnancy remain to be investigated. In this review, we collate recent studies probing the influence of FABP4 on female reproduction, pregnancy, and even fetal health. Elevated circulating FABP4 levels have been found to correlate with impaired reproductive function in women, such as polycystic ovary syndrome and endometriosis. Throughout pregnancy, FABP4 affects maternal–fetal interface homeostasis by affecting both glycolipid metabolism and immune tolerance, leading to adverse pregnancy outcomes, including miscarriage, gestational obesity, gestational diabetes, and preeclampsia. Moreover, maternal FABP4 levels exhibit a substantial linkage with the metabolic health of offspring. Herein, we discuss the emerging significance and potential application of FABP4 in reproduction and pregnancy health and delve into its underlying mechanism at molecular levels.